アズフレイヤ Medical Institute for Translational Health Sciense Official site

ASFREYA Co., Ltd. has been conducting research on how equine exosomes, particularly those derived from Thoroughbreds, affect humans, focusing on the miRNA contained within these exosomes. We are pleased to announce that we have completed the registration of two new ingredients derived from exosomes extracted from equine umbilical cord-derived mesenchymal stem cell culture supernatant and cell-conditioned culture medium from Thoroughbreds in the INCI, and we will begin handling these new cosmetic ingredients.

ASFREYA Co., Ltd. has been conducting research and development on how exosomes derived from plants and animals affect humans, including the miRNA and proteins contained within exosomes. We are pleased to announce that we have successfully extracted plant exosomes using our unique "callus culture" technology and have completed the INCI registration for cosmetic ingredients. We have successfully cultivated "callus," which is the undifferentiated cells of the herb "Tulsi (Holy Basil)," highly valued in Ayurveda as a "miraculous plant," and we will begin handling exosomes derived from Tulsi callus.

Our company has started handling the plant-derived, novel cosmetic ingredients "EXO DRF AZ" and "EXO DRFC AZ." Our exosome cosmetic novel ingredients are suitable for incorporation into skincare products, hair care products, and makeup products. The skin-beautifying effects and high anti-aging care are based on advanced science, contributing to the realization of longevity for your mind and body.

Our company will be exhibiting at the 15th COSME Week Tokyo held at Tokyo Big Sight. At Azufureiya's lab, we accept OEM/ODM joint development of cosmetics and health foods by incorporating exosome raw materials. In addition to contract manufacturing, we will begin selling botanical exosomes and microbiome exosomes, specifically "horse-derived stem cell culture supernatant," as cosmetic ingredients at this exhibition. We sincerely look forward to your visit.